Kodiak Sciences (KOD) Gains from Investment Securities (2016 - 2026)
Kodiak Sciences (KOD) reported Gains from Investment Securities of $43867.0 for Q1 2026, up 130.88% on a YoY basis from $19000.0 in Q1 2025, and down 99.8% quarter-over-quarter from $22.2 million in Q4 2025.
Kodiak Sciences (KOD) Gains from Investment Securities (2016 - 2026) Analysis & Trends
Kodiak Sciences has reported Gains from Investment Securities for 11 years, with the latest figure at $43867.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 130.88% year-over-year to $43867.0; the trailing twelve-month figure through Mar 2026 stood at $43867.0 (up 130.88% YoY), and the FY2025 full-year result was $22.2 million, up 11.83% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $43867.0, down from $22.2 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $22.2 million in Q4 2025, with the low at $4848.0 in Q1 2023.
- Historically, Gains from Investment Securities has averaged $8.5 million across 5 years, with a median of $3.7 million in 2023.
- Annual changes were most pronounced in 2024 — Gains from Investment Securities jumped 357162.29% — and 2025, when it sank 99.89%.
- Kodiak Sciences' Gains from Investment Securities stood at $16.5 million in 2022, then advanced by 6.4% to $17.6 million in 2023, then gained by 12.91% to $19.9 million in 2024, then advanced by 11.83% to $22.2 million in 2025, then tumbled by 99.8% to $43867.0 in 2026.
- The last three Gains from Investment Securities figures came in at $43867.0 (Q1 2026), $22.2 million (Q4 2025), and $23700.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,867.00 |
| Mar 31, 2026 | 43,867.00 |
| Dec 31, 2025 | 22.22 Mn |
| Dec 31, 2025 | 22.22 Mn |
| Sep 30, 2025 | 23,700.00 |
| Sep 30, 2025 | 23,700.00 |
| Jun 30, 2025 | 19.92 Mn |
| Jun 30, 2025 | 19.92 Mn |
| Mar 31, 2025 | 19,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | 19.87 Mn |
| Dec 31, 2024 | 19.87 Mn |
| Sep 30, 2024 | 4.17 Mn |
| Sep 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | 591,514.00 |
| Jun 30, 2024 | 591,514.00 |
| Mar 31, 2024 | 17.32 Mn |
| Mar 31, 2024 | 17.32 Mn |
| Dec 31, 2023 | 17.60 Mn |
| Dec 31, 2023 | 17.60 Mn |